Tianda Pharmaceuticals (HKSE:00455) Days Sales Outstanding : 72.17 (As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Tianda Pharmaceuticals Days Sales Outstanding?

Tianda Pharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2023 was HK$90.4 Mil. Tianda Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was HK$228.6 Mil. Hence, Tianda Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2023 was 72.17.

The historical rank and industry rank for Tianda Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

HKSE:00455' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.66 Med: 58.38 Max: 127.48
Current: 62.01

During the past 13 years, Tianda Pharmaceuticals's highest Days Sales Outstanding was 127.48. The lowest was 45.66. And the median was 58.38.

HKSE:00455's Days Sales Outstanding is ranked better than
59.32% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs HKSE:00455: 62.01

Tianda Pharmaceuticals's Days Sales Outstanding declined from Sep. 2022 (80.03) to Dec. 2023 (72.17).

Tianda Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Tianda Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianda Pharmaceuticals Days Sales Outstanding Chart

Tianda Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

50.06

45.66

59.45

70.48

57.10

Tianda Pharmaceuticals Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															90.77	76.62	80.03	70.19	72.17

Competitive Comparison of Tianda Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Tianda Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tianda Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianda Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Tianda Pharmaceuticals's Days Sales Outstanding falls into.

Tianda Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Tianda Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (95.631	+	70.838)	/	2 )	/	532.089	*	365
=	83.2345					/	532.089	*	365
=	57.10

Tianda Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (109.958	+	70.838)	/	2 )	/	228.605	*	365 / 2
=	90.398					/	228.605	*	365 / 2
=	72.17

Tianda Pharmaceuticals (HKSE:00455) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Tianda Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Tianda Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianda Pharmaceuticals (HKSE:00455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianda Pharmaceuticals Ltd (HKSE:00455) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

CITIC Tower, No. 1 Tim Mei Avenue, Suites 2405-2410, 24th Floor, Central, Hong Kong, HKG

Website

https://www.tiandapharma.com

Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.

Executives

Tianda Group Limited	2101 Beneficial owner
Fang Wen Quan	2201 Interest of corporation controlled by you

Tianda Pharmaceuticals (HKSE:00455) Headlines

No Headlines